Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

USA - NASDAQ:HLNE - US4074971064 - Common Stock

146.13 USD
-1.45 (-0.98%)
Last: 9/17/2025, 8:00:01 PM
146.13 USD
0 (0%)
After Hours: 9/17/2025, 8:00:01 PM
Fundamental Rating

6

Taking everything into account, HLNE scores 6 out of 10 in our fundamental rating. HLNE was compared to 237 industry peers in the Capital Markets industry. HLNE has an excellent profitability rating, but there are some minor concerns on its financial health. HLNE is valued quite expensively, but it does show have an excellent growth rating. These ratings could make HLNE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLNE was profitable.
In the past year HLNE had a positive cash flow from operations.
In the past 5 years HLNE has always been profitable.
In the past 5 years HLNE always reported a positive cash flow from operatings.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

HLNE's Return On Assets of 11.78% is amongst the best of the industry. HLNE outperforms 92.41% of its industry peers.
HLNE has a Return On Equity of 27.96%. This is amongst the best in the industry. HLNE outperforms 94.51% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.59%, HLNE belongs to the top of the industry, outperforming 95.36% of the companies in the same industry.
HLNE had an Average Return On Invested Capital over the past 3 years of 22.58%. This is significantly above the industry average of 7.61%.
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROIC 18.59%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

1.3 Margins

HLNE has a Profit Margin of 30.66%. This is in the better half of the industry: HLNE outperforms 75.95% of its industry peers.
HLNE's Profit Margin has improved in the last couple of years.
HLNE has a better Operating Margin (43.91%) than 77.64% of its industry peers.
HLNE's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 43.91%
PM (TTM) 30.66%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

The number of shares outstanding for HLNE has been increased compared to 1 year ago.
The number of shares outstanding for HLNE has been increased compared to 5 years ago.
Compared to 1 year ago, HLNE has a worse debt to assets ratio.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 6.05 indicates that HLNE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.05, HLNE belongs to the top of the industry, outperforming 87.34% of the companies in the same industry.
HLNE has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.85, HLNE belongs to the best of the industry, outperforming 89.87% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that HLNE is not too dependend on debt financing.
HLNE's Debt to Equity ratio of 0.38 is fine compared to the rest of the industry. HLNE outperforms 69.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Altman-Z 6.05
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE has a Current ratio (1.16) which is in line with its industry peers.
A Quick Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE has a Quick ratio (1.16) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. Growth

3.1 Past

HLNE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.80%.
The Earnings Per Share has been growing by 20.18% on average over the past years. This is a very strong growth
HLNE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.65%.
The Revenue has been growing by 21.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%

3.2 Future

The Earnings Per Share is expected to grow by 12.52% on average over the next years. This is quite good.
The Revenue is expected to grow by 14.19% on average over the next years. This is quite good.
EPS Next Y-0.5%
EPS Next 2Y8.96%
EPS Next 3Y12.52%
EPS Next 5YN/A
Revenue Next Year8.46%
Revenue Next 2Y11.7%
Revenue Next 3Y14.19%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.19, the valuation of HLNE can be described as expensive.
Based on the Price/Earnings ratio, HLNE is valued a bit more expensive than 70.46% of the companies in the same industry.
When comparing the Price/Earnings ratio of HLNE to the average of the S&P500 Index (27.20), we can say HLNE is valued inline with the index average.
The Price/Forward Earnings ratio is 24.42, which indicates a rather expensive current valuation of HLNE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HLNE indicates a slightly more expensive valuation: HLNE is more expensive than 64.13% of the companies listed in the same industry.
HLNE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.19
Fwd PE 24.42
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLNE is valued a bit cheaper than 66.67% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HLNE.
Industry RankSector Rank
P/FCF 24.09
EV/EBITDA 25.89
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of HLNE may justify a higher PE ratio.
A more expensive valuation may be justified as HLNE's earnings are expected to grow with 12.52% in the coming years.
PEG (NY)N/A
PEG (5Y)1.5
EPS Next 2Y8.96%
EPS Next 3Y12.52%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.40%, HLNE has a reasonable but not impressive dividend return.
HLNE's Dividend Yield is slightly below the industry average, which is at 7.96.
With a Dividend Yield of 1.40, HLNE pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 19.56%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
As HLNE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

37.04% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
The dividend of HLNE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP37.04%
EPS Next 2Y8.96%
EPS Next 3Y12.52%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (9/17/2025, 8:00:01 PM)

After market: 146.13 0 (0%)

146.13

-1.45 (-0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners104.24%
Inst Owner Change-8.62%
Ins Owners7.12%
Ins Owner Change-2.96%
Market Cap8.14B
Analysts49.09
Price Target166.06 (13.64%)
Short Float %6.19%
Short Ratio6.47
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP37.04%
Div Incr Years7
Div Non Decr Years7
Ex-Date09-19 2025-09-19 (0.54)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.26%
Min EPS beat(2)1.1%
Max EPS beat(2)27.41%
EPS beat(4)3
Avg EPS beat(4)9.11%
Min EPS beat(4)-3.63%
Max EPS beat(4)27.41%
EPS beat(8)5
Avg EPS beat(8)9.21%
EPS beat(12)8
Avg EPS beat(12)10.1%
EPS beat(16)12
Avg EPS beat(16)13.17%
Revenue beat(2)2
Avg Revenue beat(2)7.35%
Min Revenue beat(2)1.01%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)3.94%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)13.69%
Revenue beat(8)5
Avg Revenue beat(8)7.81%
Revenue beat(12)7
Avg Revenue beat(12)8.52%
Revenue beat(16)9
Avg Revenue beat(16)8.28%
PT rev (1m)2.26%
PT rev (3m)3.15%
EPS NQ rev (1m)1.27%
EPS NQ rev (3m)5.93%
EPS NY rev (1m)9.85%
EPS NY rev (3m)3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.83%
Revenue NY rev (1m)5.55%
Revenue NY rev (3m)6.88%
Valuation
Industry RankSector Rank
PE 30.19
Fwd PE 24.42
P/S 11.76
P/FCF 24.09
P/OCF 23.26
P/B 10.73
P/tB 10.73
EV/EBITDA 25.89
EPS(TTM)4.84
EY3.31%
EPS(NY)5.98
Fwd EY4.09%
FCF(TTM)6.07
FCFY4.15%
OCF(TTM)6.28
OCFY4.3%
SpS12.42
BVpS13.62
TBVpS13.62
PEG (NY)N/A
PEG (5Y)1.5
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROCE 22.22%
ROIC 18.59%
ROICexc 24.17%
ROICexgc 24.88%
OM 43.91%
PM (TTM) 30.66%
GM N/A
FCFM 48.83%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexcg growth 3Y19.01%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Debt/EBITDA 0.92
Cap/Depr 126.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 111.67%
Profit Quality 159.29%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 6.05
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
EPS Next Y-0.5%
EPS Next 2Y8.96%
EPS Next 3Y12.52%
EPS Next 5YN/A
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%
Revenue Next Year8.46%
Revenue Next 2Y11.7%
Revenue Next 3Y14.19%
Revenue Next 5YN/A
EBIT growth 1Y8.35%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year-0.77%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y55.62%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y56.53%
OCF growth 3Y21.07%
OCF growth 5Y20.91%